Background Module Title

Description
CTA Button

Share Price

As at December 3rd 2021 5:19 PM

$0.235 | -0.005 (-2.08%)

ASX

Key Dates

June 5th 2021

Key Date

Key Dates

5 June 2021 Key Date

ASX Headline

Date Heading
November 18th 2021 CEO and Chairman Presentation
October 15th 2021 Investor Presentation
August 27th 2021 FY21 Results Investor Presentation
June 15th 2021 Investor Presentation
May 4th 2021 Investor Presentation
February 26th 2021 FY21 Half Year Results Presentation

ASX Price

Last Price

$0.235 | -0.005 (-2.08%)

December 3rd 2021 5:19 PM

Content Editor

Lorem ipsum dolor sit amet, ea utroque pertinax indoctum cum, cum id solet repudiare. Nam ea iisque blandit neglegentur. Vim meis dolorem vituperatoribus te, putent invenire accusamus no eos. Inani epicuri splendide ei vim. Causae molestie mnesarchum ius te, nec audiam salutandi ne, tantas graece persequeris mel in. Duo at mundi aperiam, in vis noster qualisque.

Link

Team Members

sanjeev_Alfred_
+

Dr Sanjeev Alfred

Chief Commercial Officer

Sanjeev joined Haemokinesis in April 2021. Sanjeev has substantial experience in the immunohaematology and clinical diagnostics sector joining us, from Bio-Rad Laboratories (BIO:NYSE). Sanjeev was previously the Regional Manager (South Pacific Region), Clinical Diagnostics Group at Bio-Rad and prior to that was the Regional Marketing Manager (Asia-Pacific) at Thermo Fisher Scientific (TMO:NYSE).

Sanjeev has more than 15 years of experience in the Life Science and Clinical diagnostic markets. Furthermore, he has significant experience in establishing distributors and large-scale distributor networks. Sanjeev holds a PhD (Biological Sciences) from the University of Sydney along with an Executive MBA from the Australian Catholic University. He is also a member of the Australian Institute of Company directors.

Siobhan_McAndrew
+

Siobhan McAndrew

Production Manager

Siobhan joined Haemokinesis in 2012 as Production Manager soon after Haemokinesis was established. Siobhan has over 16 years’ experience in the Immunohaemolatology Industry starting her career with Dia-Med Australia before moving on to Lateral Grifols. She moved from Ireland to Australia in 2004 after completing a 4 years honours degree in Bachelor of Science, majoring in Industrial Microbiology from University College Dublin (UCD).

During her career she has worked on Research, Design and Production of Diagnostic reagents. Siobhan has brought her knowledge and skill into the product development of Haemokinesis reagent portfolio and is committed to producing products of a high quality standard.

Jim_manolios
+

Jim Manolios

Chief Executive Officer and Managing Director

Jim Manolios is the Managing Director of Haemokinesis and founding the company in 2011, bringing more than 37 years in diagnostics pathology and 30 years in Blood Banking to the company along with substantial experience in gel manufacturing, instrument automation and biochemistry.

Jim previously co-founded DiaMedAustralia and Lateral Grifols B, along with other companies specialising in immunohaematology products with production sites in Australia.

Lou_Panaccio
+

Lou Panaccio

Non-Executive Director

Lou Panaccio is the Non-Executive Director at Haemokinesis and brings extensive experience working in corporate healthcare in senior management positions including as the Chairman of Health Networks Australia and the CEO of Melbourne Pathology.

He is currently a non-executive Director of ASX listed companies Sonic Healthcare Ltd (SHL.ASX), Avita Therapeutics, Inc (AVH.ASX) and Rhythm Biosciences Ltd (RHY.ASX). He is also the Non-Executive Director of Unison Housing Ltd.

Alex_Abrahams-
+

Dr Alex Abrahams

Non-Executive Director

Dr Alex Abrahams, a Non-Executive Director at Haemokinesis and brings substantial experience in the dentistry and corporate health sector. He was a founder and major shareholder of Pacific Smiles Ltd (ASX.PSQ) and now retired as a Non-Executive Director

Alex is also a Non-Executive Director of MicroEquities Asset Management Ltd (ASX.MAM), major shareholder and Executive Chairman of Group Homes Australia Pty Ltd (unlisted).

Debbie_Ormsby
+

Debbie Ormsby

Non-Executive Director

Ms Ormsby is a senior executive with over 25 years’ experience across the pharmaceutical and biotech industries both domestically and globally.

Prior corporate roles include ANZ Country Head and General Manager of The Medicines Company (acquired by Novartis), ANZ Country Head and Managing Director of Meda Pharmaceuticals, APAC Regional Medical Director of Actelion Pharmaceuticals (acquired by Janssen), Global Study Leader at Roche Products Ltd (UK) and Chief Commercial Officer of THC Global (THC.ASX).

Ms Ormsby has a cross-functional background with extensive experience in strategy development and implementation including leadership of start-up organisations, go-to-market strategies and end to end product commercialisation. Her career spans highly specialised medical markets with a particular emphasis on haematology, virology and cardiovascular. She is a registered pharmacist and is currently Director, Commercialisation at The Heart Research Institute.

Conn-Pasakos
+

Conn Pasakos

Chief Financial Officer

Conn Pasakos was appointed as the Chief Financial Officer for Haemokinesis in September 2020 and has more than 30 years commercial experience including senior finance positions across manufacturing wholesale distribution and IT&T. Conn has previously worked in senior accounting and financial advisory roles at PwC and Deloitte.

Michael_Ohanessian
+

Michael Ohanessian

Non-Executive Director

Michael Bernard Ohanessian is the Non-Executive Director at Haemokinesis and brings extensive experience gained from technology-related businesses with a mixture of operational, strategic and leadership capabilities. Following a ten-year career at Mobil Oil, Michael joined the Boston Consulting Group where he consulted to clients in a wide range of industries which include banking, airlines, mining, packaging, sports, oil and gas, retailing and biotechnology.
Michael then became the CEO of Vision BioSystems (now Leica BioSystems) where he led a transformation over seven years into a globally successful medical diagnostics company. He has also served as CEO and Managing Director of ASX-listed Genetic Technologies Limited and has been involved in investment management and corporate advice with Lion Capital. Michael then joined ASX-listed Praemium Limited as its CEO and Managing Director from 2011 to 2021. Michael was a Non-Executive Director of the SGP Group of Companies (now Trajan) and has been a Non-Executive Director of ASX-listed Bluechiip since 2014.

+

David Bashforth

David Bashforth

David Bashforth brings a wealth of knowledge and experience to the management team at Haemokinesis.

+

Naomi Stabey

Quality Systems Specialist

XXXXXXXXXXXXXX

Mark_Benson
+

Mark Benson

Applications and Service Manager

Mark has over 40 years’ experience in the clinical diagnostics sector. Prior to joining Haemokinesis in June 2016, Mark has held many senior technical support roles at Beckman Coulter, DiaMed and Grifols.

Raoul_Cadei
+

Raoul Cadei

Instrument & Software Operating Officer

Raoul has been involved with Haemokinesis since 2014, where he was in charge of software development before joining the company in 2018, when he became COO and implemented software and instrument production improvements. Raoul’s extensive experience, including IT knowledge, saw him work as a consultant for some of the most important companies in Italy and abroad: the Italian Automobile Club (ACI), Publitalia’80 (Mediaset Group) and other top International Motorsport Federations.

In more than 25 years, Raoul learned to master many different technologies, particularly focused on the development of complex and functional product management architectures. His passion for streamlining industry and processes brought him to become a certified Six Sigma Black Belt, with also a certification in Scrum Agile project management.

Armin_Kochli
+

Armin Köchli

Global Marketing Manager

In August 2018, Armin joined Haemokinesis as Global Sales and Marketing Manager. Previously, Armin was at DiaMed for 17 years and Bio-Rad as a Division Marketing Manager. Armin has extensive knowledge and experience in the immunohaematology field.

Armin was previously the Division Marketing Manager at Bio-Rad for the Immunohaematology Division and has introduced new automated solutions to the market as well as several new blood grouping tests. Armin has more than 25 years experience in the Clinical diagnostic market. Armin started his career as a bio-medical scientist and later studied for Master in Marketing in Bern, Switzerland.

Karen-Montgomery
+

Karen Montgomery-Douglas

Regional Sales Manager (Asia-Pacific)

Karen joined Haemokinesis in June 2021. Karen has over 25 years’ experience in immunohaemotology. Qualified as a Medical Scientist, BSc (Biomedical) Post Graduate Diploma in Medical Laboratory Science, Karen has worked in the Pathology Industry in Australia and the United Kingdom, including core pathology, immunohaematology as well as specialised clinical testing, clinical instrumentation and enterprise laboratory systems.

Karen has 15 years of Sales and Marketing experience in Clinical Diagnostics working at Ortho Clinical Diagnostics as a Key Account Manager for both Immunohaematology and Clinical Chemistry Solutions and Laboratory Informatics working at LabWare LIMS as the Oceania Sales Manager.

Column Content 1

Lorem ipsum dolor sit amet, ea utroque pertinax indoctum cum, cum id solet repudiare. Nam ea iisque blandit neglegentur. Vim meis dolorem vituperatoribus te, putent invenire accusamus no eos. Inani epicuri splendide ei vim. Causae molestie mnesarchum ius te, nec audiam salutandi ne, tantas graece persequeris mel in. Duo at mundi aperiam, in vis noster qualisque.

Column Content 2

Lorem ipsum dolor sit amet, ea utroque pertinax indoctum cum, cum id solet repudiare. Nam ea iisque blandit neglegentur. Vim meis dolorem vituperatoribus te, putent invenire accusamus no eos. Inani epicuri splendide ei vim. Causae molestie mnesarchum ius te, nec audiam salutandi ne, tantas graece persequeris mel in. Duo at mundi aperiam, in vis noster qualisque.

Content Tabs

Tab 1 Title

<p>Lorem ipsum dolor sit amet, ea utroque pertinax indoctum cum, cum id solet repudiare. Nam ea iisque blandit neglegentur. Vim meis dolorem vituperatoribus te, putent invenire accusamus no eos. Inani epicuri splendide ei vim. Causae molestie mnesarchum ius te, nec audiam salutandi ne, tantas graece persequeris mel in. Duo at mundi aperiam, in vis noster qualisque.</p>
Link

Tab 2 Title

<p>Lorem ipsum dolor sit amet, ea utroque pertinax indoctum cum, cum id solet repudiare. Nam ea iisque blandit neglegentur. Vim meis dolorem vituperatoribus te, putent invenire accusamus no eos. Inani epicuri splendide ei vim. Causae molestie mnesarchum ius te, nec audiam salutandi ne, tantas graece persequeris mel in. Duo at mundi aperiam, in vis noster qualisque.</p>
Link

Content Slider

Lorem ipsum dolor sit amet, ea utroque pertinax indoctum cum, cum id solet repudiare. Nam ea iisque blandit neglegentur. Vim meis dolorem vituperatoribus te, putent invenire accusamus no eos. Inani epicuri splendide ei vim. Causae molestie mnesarchum ius te, nec audiam salutandi ne, tantas graece persequeris mel in. Duo at mundi aperiam, in vis noster qualisque.

Lorem ipsum dolor sit amet, ea utroque pertinax indoctum cum, cum id solet repudiare. Nam ea iisque blandit neglegentur. Vim meis dolorem vituperatoribus te, putent invenire accusamus no eos. Inani epicuri splendide ei vim. Causae molestie mnesarchum ius te, nec audiam salutandi ne, tantas graece persequeris mel in. Duo at mundi aperiam, in vis noster qualisque.

1 / ?

Image Content

Lorem ipsum dolor sit amet, ea utroque pertinax indoctum cum, cum id solet repudiare. Nam ea iisque blandit neglegentur. Vim meis dolorem vituperatoribus te, putent invenire accusamus no eos. Inani epicuri splendide ei vim. Causae molestie mnesarchum ius te, nec audiam salutandi ne, tantas graece persequeris mel in. Duo at mundi aperiam, in vis noster qualisque.

Link

Image Content Alt

Lorem ipsum dolor sit amet, ea utroque pertinax indoctum cum, cum id solet repudiare. Nam ea iisque blandit neglegentur. Vim meis dolorem vituperatoribus te, putent invenire accusamus no eos. Inani epicuri splendide ei vim. Causae molestie mnesarchum ius te, nec audiam salutandi ne, tantas graece persequeris mel in. Duo at mundi aperiam, in vis noster qualisque.

Link
Client Icons

Lorem ipsum dolor sit amet, ea utroque pertinax indoctum cum, cum id solet repudiare. Nam ea iisque blandit neglegentur. Vim meis dolorem vituperatoribus te, putent invenire accusamus no eos. Inani epicuri splendide ei vim. Causae molestie mnesarchum ius te, nec audiam salutandi ne, tantas graece persequeris mel in. Duo at mundi aperiam, in vis noster qualisque.

Client 1

Client 2

Client 3

Client 4

Complex Content

Lorem ipsum dolor sit amet, ea utroque pertinax indoctum cum, cum id solet repudiare. Nam ea iisque blandit neglegentur. Vim meis dolorem vituperatoribus te, putent invenire accusamus no eos. Inani epicuri splendide ei vim. Causae molestie mnesarchum ius te, nec audiam salutandi ne, tantas graece persequeris mel in. Duo at mundi aperiam, in vis noster qualisque.

Lorem ipsum dolor sit amet, ea utroque pertinax indoctum cum, cum id solet repudiare. Nam ea iisque blandit neglegentur. Vim meis dolorem vituperatoribus te, putent invenire accusamus no eos. Inani epicuri splendide ei vim. Causae molestie mnesarchum ius te, nec audiam salutandi ne, tantas graece persequeris mel in. Duo at mundi aperiam, in vis noster qualisque.

Lorem ipsum dolor sit amet, ea utroque pertinax indoctum cum, cum id solet repudiare. Nam ea iisque blandit neglegentur. Vim meis dolorem vituperatoribus te, putent invenire accusamus no eos. Inani epicuri splendide ei vim. Causae molestie mnesarchum ius te, nec audiam salutandi ne, tantas graece persequeris mel in. Duo at mundi aperiam, in vis noster qualisque.

Lorem ipsum dolor sit amet, ea utroque pertinax indoctum cum, cum id solet repudiare. Nam ea iisque blandit neglegentur. Vim meis dolorem vituperatoribus te, putent invenire accusamus no eos. Inani epicuri splendide ei vim. Causae molestie mnesarchum ius te, nec audiam salutandi ne, tantas graece persequeris mel in. Duo at mundi aperiam, in vis noster qualisque.

Form (Needs GForm ID)

Lorem ipsum dolor sit amet, ea utroque pertinax indoctum cum, cum id solet repudiare. Nam ea iisque blandit neglegentur. Vim meis dolorem vituperatoribus te, putent invenire accusamus no eos. Inani epicuri splendide ei vim. Causae molestie mnesarchum ius te, nec audiam salutandi ne, tantas graece persequeris mel in. Duo at mundi aperiam, in vis noster qualisque.

Contact Us
  • This field is for validation purposes and should be left unchanged.

Block Slider

Accordion

Lorem ipsum dolor sit amet, ea utroque pertinax indoctum cum, cum id solet repudiare. Nam ea iisque blandit neglegentur. Vim meis dolorem vituperatoribus te, putent invenire accusamus no eos. Inani epicuri splendide ei vim. Causae molestie mnesarchum ius te, nec audiam salutandi ne, tantas graece persequeris mel in. Duo at mundi aperiam, in vis noster qualisque.

Lorem ipsum dolor sit amet, ea utroque pertinax indoctum cum, cum id solet repudiare. Nam ea iisque blandit neglegentur. Vim meis dolorem vituperatoribus te, putent invenire accusamus no eos. Inani epicuri splendide ei vim. Causae molestie mnesarchum ius te, nec audiam salutandi ne, tantas graece persequeris mel in. Duo at mundi aperiam, in vis noster qualisque.

Content table

Head 1 Head 2 Head 3
Content 1 Content 2 Content Link 3